Provider Reviews

Try Ageless vs Telos Rx: Compare pricing, formats, and approvals

Try Ageless vs Telos Rx answers whether you want format choice or the lowest advertised entry price. Early verdict: Try Ageless stands out for offering three GLP-1 formats including needle-free tirzepatide oral drops and built-in discounts, while Telos Rx highlights lower as-low-as monthly pricing that is subject to clinician approval and plan terms.

See Try Ageless plans and formats

How the two programs differ at a glance

This comparison focuses on the most distinctive supported differences: available medication formats, advertised starting prices and pricing structure, discount and billing terms, clinician approval and eligibility wording, and regulatory status of the medications.

1) Medication formats and switching

Try Ageless sells three GLP-1 formats: compounded semaglutide injection, compounded tirzepatide injection, and needle-free tirzepatide oral drops, and explicitly allows clinicians to switch molecules or formats under one plan with no new consult fee. Telos Rx offers compounded semaglutide and tirzepatide but captured evidence does not show a needle-free oral tirzepatide option or explicit format-switching policy.

Check Telos Rx pricing and eligibility

2) Starting prices and how they are presented

Try Ageless lists formats with stated start points on yearly plans: tirzepatide oral drops from $159/mo, semaglutide from $199/mo, tirzepatide injection from $249/mo, with the site saying the discount is built into every plan. Telos Rx advertises as low as prices: semaglutide from $99 per month and tirzepatide from $139 per month, but emphasizes that pricing and eligibility depend on clinician approval and the live offer.

3) Discounts, billing structure, and plan commitments

Try Ageless states a discount already applied to every plan and an extra code SLIM50 that stacks for $50 off every order; it markets prepaid yearly pricing as the lowest entry. Telos Rx presents as-low-as monthly pricing and notes you pay $0 if not approved in captured text; captured evidence warns pricing, eligibility, pharmacy, state coverage and renewal terms may change and that your price depends on your plan.

4) Clinician review, eligibility, and availability

Both providers require prescription and clinician review. Try Ageless says licensed U.S. clinicians prescribe the compounded products and that plans are subject to a prescription via telehealth and state availability limits. Telos Rx repeatedly notes that semaglutide and tirzepatide are prescription-only and prescribed only after review by a U.S. licensed provider, and that treatment is available only when a licensed clinician determines it is medically appropriate.

5) Regulatory status and what that means

Both providers’ captured evidence includes the regulatory caution that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality. Try Ageless explicitly notes the oral tirzepatide drops are an off-label compounded format because tirzepatide is not FDA-approved in oral form.

Comparison table

Criteria Try Ageless Telos Rx
Formats offered Semaglutide injection, tirzepatide injection, tirzepatide oral drops Compounded semaglutide and tirzepatide (injection formats captured)
Starting price advertised Oral drops from $159/mo; semaglutide from $199/mo; tirzepatide from $249/mo (yearly plans) Semaglutide as low as $99/mo; tirzepatide as low as $139/mo (subject to approval)
Discounts and codes Discount already applied to every plan; extra $50 off with code SLIM50 As-low-as pricing; captured evidence warns terms may change
Clinician approval Prescribed by licensed U.S. clinicians via telehealth; switching allowed under plan Prescribed only after review by a U.S. licensed provider; subject to medical approval
Regulatory note Compounded medications not FDA-approved; oral tirzepatide is off-label compounded format Compounded medications not FDA-approved; availability subject to clinician review
Shipping and cancellation Free discreet shipping; cancel anytime; plain discreet packaging Captured evidence indicates cancel anytime; terms and state coverage may change

Practical differences that matter

If you prioritize a needle-free tirzepatide option and built-in discounted yearly pricing, Try Ageless documents both clearly and advertises the oral drops from $159/mo. If your decision hinges on the lowest as-low-as monthly number and you accept pricing conditional on clinician approval and plan terms, Telos Rx presents lower advertised entry pricing in captured text.

View Try Ageless formats and pricing

Safety, approvals, and claims to note

Neither provider in the captured evidence offers FDA approval for the compounded medications. Try Ageless explicitly flags that compounded medications are not FDA-approved and that oral tirzepatide is an off-label compounded format. Telos Rx also states compounded medications are not FDA-approved and that treatment is subject to a licensed clinician deciding it is appropriate. Individual results vary and are not guaranteed; outcome claims on landing pages are user examples and not universal results.

Explore Try Ageless details and clinician options

Conclusion: Choose based on format preference and pricing certainty

Try Ageless vs Telos Rx boils down to format choice and how pricing is presented. Choose Try Ageless if you want a documented needle-free tirzepatide oral drops option, built-in discounts on plans, bundled B12, and explicit format switching under one plan. Choose Telos Rx if you prioritize the lowest advertised as-low-as monthly figures in the captured evidence and accept that final pricing and eligibility are subject to clinician approval and plan terms. Both providers dispense compounded semaglutide and tirzepatide prescribed online, and both note compounded medications are not FDA-approved.

Check Telos Rx clinician-reviewed pricing

Ready to Compare Telehealth Providers?

Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.

Compare All Providers →

More comparisons

SkinnyRx logo
Provider ReviewsSkinnyRx vs Try Ageless: oral semaglutide vs multiple GLP-1 formatsSkinnyRx offers daily oral semaglutide tablets from $249/mo with FSA/HSA eligibility and free overnight shipping. Try Ageless offers three GLP-1 formats from $159/mo.September 20, 2026
Shed logo
Provider ReviewsShed vs Try Ageless: Coaching and Formats ComparedShed offers name-brand and compounded GLP-1 with integrated coaching and a 2-minute assessment, compounded semaglutide starting at $199. Try Ageless sells compounded formats from $159 with needle-free drops.September 19, 2026
Sesame Care logo
Provider ReviewsSesame Care vs Try Ageless: Telehealth choice or low-cost formatsSesame Care offers a clinician-choice marketplace and insurance options, while Try Ageless sells compounded GLP-1s including needle-free tirzepatide drops from $159/mo.September 18, 2026
Found logo
Provider ReviewsFound vs Telos Rx: Biology-First Plans vs Compounded GLP-1 PricingFound: personalized medically supervised program starting at $39, most insurance now accepted; compounded GLP-1s not FDA-approved. Telos Rx: semaglutide from $99, tirzepatide from $139 and clinician review required.September 6, 2026
Enhance MD logo
Provider ReviewsEnhance MD vs Telos Rx: Semaglutide and Tirzepatide Pricing GuideEnhance MD starts semaglutide at $49 first month and tirzepatide at $99; Telos Rx lists semaglutide as low as $99 and tirzepatide as low as $139, both clinician-reviewed and compounded.September 5, 2026
Embody logo
Provider ReviewsEmbody vs Telos Rx: Low-Cost Compounded GLP-1 Options ComparedEmbody offers compounded semaglutide at $69/month and tirzepatide $119 with free 1–2 day shipping; Telos Rx lists semaglutide from $99 and tirzepatide from $139, subject to clinician approval.September 4, 2026

Medical disclaimer: This page is for informational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any treatment. We may earn a commission from partner links on this page - see our advertising disclosure.